A novel vaccine strategy using quick and easy conversion of bacterial pathogens to unnatural amino acid-auxotrophic suicide derivatives
Preprint
Abstract
We propose a novel strategy for quick and easy preparation of suicide live vaccine candidates against bacterial pathogens. This method requires only the transformation of one or more plasmids carrying genes encoding for two types of biological devices, an unnatural amino acid (uAA) incorporation system and toxin-antitoxin systems in which translation of the antitoxins requires the uAA incorporation. Escherichia coli BL21-AI laboratory strains carrying the plasmids were viable in the presence of the uAA, whereas the free toxins killed these strains after removal of the uAA. The survival time after uAA removal could be controlled by the choice of uAA incorporation system and toxin-antitoxin systems. Multilayered toxin-antitoxin systems suppressed escape frequency to less than 1 escape per 10 9 generations in the best case. This conditional suicide system also worked in Salmonella enterica and E. coli clinical isolates. The S. enterica vaccine strains were attenuated with a >10 5 -fold lethal dose. Serum IgG response and protection against the parental pathogenic strain were confirmed. In addition, the live E. coli vaccine strain was significantly more immunogenic and provided greater protection than a formalin-inactivated vaccine. The live E. coli vaccine was not detected after inoculation, presumably because the uAA is not present in the host animals or in the natural environment. These results suggest that this strategy provides a novel way to rapidly produce safe and highly immunogenic live bacterial vaccine candidates. Significance: Live vaccines are the oldest vaccines with a history of more than 200 years. Due to their strong immunogenicity, live vaccines are still an important category of vaccines today. However, the development of live vaccines has been challenging due to the difficulties in achieving a balance between safety and immunogenicity. In recent decades, the frequent emergence of various new and old pathogens at risk of causing pandemics has highlighted the need for rapid vaccine development processes. We have pioneered the use of unnatural amino acids to control gene expression and to conditionally kill host bacteria as a biological containment system. This report highlights a quick and easy conversion of bacterial pathogens into live vaccine candidates using this containment system.Keywords
All Related Versions
- Published version: Microbiology Spectrum, 12 (4), e0355723.
This publication has 70 references indexed in Scilit:
- Risk in Vaccine Research and Development QuantifiedPLOS ONE, 2013
- Toxin-antitoxin systems are ubiquitous and versatile modulators of prokaryotic cell fateFEMS Microbiology Letters, 2013
- Salmonella enterica: a surprisingly well-adapted intracellular lifestyleFrontiers in Microbiology, 2012
- RF1 knockout allows ribosomal incorporation of unnatural amino acids at multiple sitesNature Chemical Biology, 2011
- Codon reassignment in the Escherichia coli genetic codeNucleic Acids Research, 2010
- Fluctuation AnaLysis CalculatOR: a web tool for the determination of mutation rate using Luria–Delbrück fluctuation analysisBioinformatics, 2009
- Genetic Encoding of 3-Iodo-l-Tyrosine in Escherichia coli for Single-Wavelength Anomalous Dispersion Phasing in Protein CrystallographyStructure, 2009
- Shiga Toxin-Mediated Disease in MyD88-Deficient Mice Infected with Escherichia coli O157:H7The American Journal of Pathology, 2008
- Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containmentProceedings of the National Academy of Sciences, 2008
- Pathogenic Escherichia coliNature Reviews Microbiology, 2004